Quality of life for hepatitis C patients with a formulation for administration to the oral mucosa including Lactobacillus delbrueckii subsp. bulgaricus and N-acetyl D-glucosamine
OwnerCarl Millerinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerCarl Millerinventor
Estimating the term…
Disclosed are quick dissolve tablets, each including Lactobacillus delbrueckii subsp bulgaricus (LBD) and N-acetyl-glucosamine (NAG), as well as excipients, for oral mucosal administration, for improving the quality of life of Hepatitis C patients. Any formulation suitable for oral mucosal administration can be employed for administering the active ingredients in a sufficient dosage for therapeutic effect, one such formulation being: 50 mg of Lactobacillus delbrueckii subsp bulgaricus lysate strain YB-I 10 mg of N-acetyl D-glucosamine. Excipients can include one or more of, maltodextrin; xanthan gum; acesulfam K; lemon powder and a flavoring, e.g., juice; Mannitol TL-32-04, Microcrystalline Cellulose and Carrageenan, Fructose, PVP-XL TL-11-04, Gellan Gum, Citrus TL 1-04, Orange TL 19-04, Sucrolose TL-13-04, and Mg ST TL-13-04.
A formulation to treat Hepatitis C infected patients, active ingredients of said formulation consisting essentially of:
A fast dissolving tablet for treating Hepatitis C infected patients, said tablet consisting of active ingredients and excipients, said active ingredients being four parts of Lactobacillus delbrueckii subsp bulgaricus freeze dried lysate, and one part of N-acetyl-glucosamine.
A formulation to improve quality of life of Hepatitis C patients by a two point or greater improvement in SF-36 scores, active ingredients of said formulation consisting essentially of:
Dependencies are inferred from the claim text.